| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205
ANG II exerts a biphasic effect on
Na+ transport in the kidney through its effects on
Na+-K+-ATPase activity. Beginning at
10
13 M, ANG II increased
Na+-K+-ATPase activity in freshly isolated rat
proximal tubules to a maximum stimulation at 1011 M of
1.43 ± 0.08-fold above control. Stimulation decreased
progressively at concentrations >1010 M to a value of
0.96 ± 0.1-fold at 107 M. In the presence of
additional L-arginine, the substrate for NO synthesis, the
stimulatory effect of ANG II (1011 M) was lost.
Conversely, N-monomethyl-L-arginine
(L-NMMA), the nitric oxide (NO) synthase inhibitor,
unmasked the stimulatory effect of ANG II at 107 M
(1.40 ± 0.1-fold).
1H-[1,2,4]oxadiazole-[4,3-a]quinoxalin-1-one, the
soluble guanylyl cyclase inhibitor, like L-NMMA, unmasked the stimulatory effect of ANG II at 107 M (1.30 ± 0.1-fold). The intracellular cGMP concentration was increased 1.58 ± 0.28-fold at 107 M ANG II. The ANG II AT1
receptor antagonist SK&F 108566 blocked the stimulatory effect of ANG
II at 1011 M. These data suggest that the NO/cGMP
signaling pathway serves as a negative component in the regulation of
Na+-K+-ATPase activity by ANG II.
N-monomethyl-L-arginine; 1H-[1,2,4]oxadiazole-[4,3-a]quinoxalin-1-one; SK&F 108566; angiotensin II
This article has been cited by other articles:
|
|
 |
|
  A. A. Banday and M. F. Lokhandwala Loss of Biphasic Effect on Na/K-ATPase Activity by Angiotensin II Involves Defective Angiotensin Type 1 Receptor-Nitric Oxide Signaling Hypertension, December 1, 2008; 52(6): 1099 - 1105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Tiwari, R. W. Brock, J. K. Megyesi, G. P. Kaushal, and P. R. Mayeux Disruption of renal peritubular blood flow in lipopolysaccharide-induced renal failure: role of nitric oxide and caspases Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1324 - F1332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Notenboom, D. S. Miller, P. Smits, F. G. M. Russel, and R. Masereeuw Involvement of guanylyl cyclase and cGMP in the regulation of Mrp2-mediated transport in the proximal tubule Am J Physiol Renal Physiol, July 1, 2004; 287(1): F33 - F38. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Graebe, L. Brond, S. Christensen, S. Nielsen, N. V. Olsen, and T. E. N. Jonassen Chronic nitric oxide synthase inhibition exacerbates renal dysfunction in cirrhotic rats Am J Physiol Renal Physiol, February 1, 2004; 286(2): F288 - F297. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. K. Tipsmark and S. S. Madsen Regulation of Na+/K+-ATPase activity by nitric oxide in the kidney and gill of the brown trout (Salmo trutta) J. Exp. Biol., May 1, 2003; 206(9): 1503 - 1510. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wei and W. Wang Angiotensin II stimulates basolateral K channels in rat cortical collecting ducts Am J Physiol Renal Physiol, January 1, 2003; 284(1): F175 - F181. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Notenboom, D. S. Miller, P. Smits, F. G. M. Russel, and R. Masereeuw Role of NO in endothelin-regulated drug transport in the renal proximal tubule Am J Physiol Renal Physiol, March 1, 2002; 282(3): F458 - F464. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
